InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
4
T+90 hit rate
30%
T+90 mean return
+0.6%
Across 10 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by Leite John, Directeur Commercial. Insider active across 1 company, notably Veracyte, INC.. Cumulatively, 15 disclosures have been logged. Breakdown: 0 buy · 4 sells. Total volume traded: €328k. Activity tracked since 2 September 2023. The latest transaction was disclosed on 2 December 2025 (Retenue fiscale). Regulator: SEC (Form 4). The full history is openly available.
Declarations15 total
2,900 shares@ US$46.1630.2% of flowCommon StockSEC:0001991536-25-000008
2,900 shares@ US$46.160.0038% mcap30.2% of flowCommon StockSEC:0001991536-25-000008:0
2,539 shares@ US$35.0019.8% of flowCommon StockSEC:0001991536-25-000004
2,539 shares@ US$35.000.0025% mcap19.8% of flowCommon StockSEC:0001991536-25-000004:0
36,240 shares0Common StockSEC:0001384101-25-000042:0
11,006 shares0Common StockSEC:0001384101-25-000026:0
1,314 shares@ US$44.126.8% of flowCommon StockSEC:0001384101-24-000181:0
5,479 shares@ US$29.77918.1% of flowCommon StockSEC:0001384101-24-000153:0
1,315 shares@ US$31.554.6% of flowCommon StockSEC:0001384101-24-000146:0
1,277 shares@ US$25.003.6% of flowCommon StockSEC:0001384101-24-000110:0
1,314 shares@ US$20.753.1% of flowCommon StockSEC:0001384101-24-000076:0
49,880 shares0Common StockSEC:0001384101-24-000040:0
3,008 shares@ US$24.008.2% of flowCommon StockSEC:0001384101-24-000025:0
556 shares@ US$26.541.7% of flowCommon StockSEC:0001384101-23-000170:0
2,222 shares@ US$26.706.7% of flowCommon StockSEC:0001384101-23-000146:0
15 of 15 declarations
About Leite John
John Leite is the Chief Commercial Officer-CLIA at Veracyte, Inc. He is responsible for the company's commercial direction, including business development and customer relationship management. His role is essential in ensuring revenue growth and market expansion. John leverages his expertise to guide strategic decisions and strengthen Veracyte's market position.
